Related Experiment Video
Updated: Aug 28, 2026

Ex Vivo Imaging of Resident CD8 T Lymphocytes in Human Lung Tumor Slices Using Confocal Microscopy
Published on: December 27, 2017
Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease
C Agostini1, R Zambello, R Sancetta
1Padua University School of Medicine, Department of Clinical and Experimental Medicine, Padua, Italy.
Abstract:
Recently, a novel receptor superfamily has been identified whose members interact with a parallel family of ligands showing homology to tumor necrosis factor (TNF). To investigate the role of these receptor structures in the pulmonary environment, we evaluated the expression of some members of the TNF-receptor (CD27, CD30, CD40, CD95/Fas, CD120a, and CD120b) and TNF-ligand (CD40L, CD70/CD27L, CD30L, and mTNFalpha) superfamilies by bronchoalveolar lavage (BAL) T cells recovered from healthy subjects and patients with interstitial lung disease (ILD). Lung T lymphocytes recovered from control subjects showed a slight expression of CD27 but did not bear CD30, CD40, CD120a, or CD120b antigens. CD27 expression was restricted to normal CD4+ cells. Fas antigen (CD95), which is involved in activation-driven T-cell suicide, and the ligand for CD27 (CD70) were weakly expressed by normal BAL T-cell subpopulations. In patients with sarcoidosis, the majority of pulmonary T lymphocytes were CD4+ cells that expressed low levels of CD27 antigen and an upregulation of CD95 and CD70 molecules. When we characterized lymphocytes accumulating in the lung of patients with HIV infection and hypersensitivity pneumonitis, we demonstrated that T cells accounting for the CD8 alveolitis bore TNF-receptor type 2 (CD120b) at high density and were CD70+ while CD40L, CD30L, or mTNF-alpha expression were not found. The discrete surface expression of the TNF-receptors and TNF-ligands on alveolar T-cell subsets suggests that these molecules play a role in the immune regulatory mechanisms that ultimately lead to the alveolitis in the pulmonary microenvironment of interstitial lung disease.
Insights
Tumor necrosis factor (TNF) receptors and ligands are expressed on lung T cells in interstitial lung disease (ILD). This suggests their role in pulmonary immune regulation and alveolitis development in ILD patients.
Area of Science:
- Immunology
- Pulmonary Medicine
- Cell Biology
Background:
- A novel superfamily of receptors interacting with tumor necrosis factor (TNF)-homologous ligands has been identified.
- The role of these TNF-receptor and TNF-ligand superfamilies in the pulmonary environment remains largely unexplored.
Purpose of the Study:
- To investigate the expression of key TNF-receptor and TNF-ligand members on bronchoalveolar lavage (BAL) T cells.
- To evaluate the differential expression patterns in healthy subjects versus patients with interstitial lung disease (ILD).
Main Methods:
- Analysis of T cells from BAL of healthy controls and patients with ILD (sarcoidosis, HIV infection, hypersensitivity pneumonitis).
- Flow cytometry was used to assess the surface expression of specific TNF-receptors (CD27, CD30, CD40, CD95/Fas, CD120a, CD120b) and TNF-ligands (CD40L, CD70, CD30L, mTNFalpha).
Main Results:
- Healthy controls showed minimal expression of most receptors/ligands, with CD27 on CD4+ cells and weak CD95/CD70 expression.
- ILD patients exhibited distinct patterns: sarcoidosis patients had upregulated CD95 and CD70 on CD4+ T cells.
- HIV and hypersensitivity pneumonitis patients showed CD8 alveolitis with high CD120b and CD70 expression.
Conclusions:
- Discrete surface expression of TNF-receptors and ligands on alveolar T cells suggests their involvement in immune regulation.
- These molecules likely contribute to the alveolitis observed in the pulmonary microenvironment of ILD.
More Related Videos
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024